Flow Traders U.S.’s Novo Nordisk NVO Stock Holding History

Flow Traders U.S.’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Sell	28,210 -3,986	-12%	-$189K	0.03%	441
2025 Q4	$1.64M	Sell	32,196 -8,925	-22%	-$456K	0.05%	252
2025 Q3	$2.28M	Buy	41,121 +34,654	+536%	+$2.03M	0.09%	211
2025 Q2	$446K	Sell	6,467 -16,997	-72%	-$1.16M	0.02%	639
2025 Q1	$1.63M	Buy	+23,464	New	+$1.94M	0.07%	269
2024 Q4	–	Sell	-24,792	Closed	-$2.95M	–	1218
2024 Q3	$2.95M	Buy	24,792 +22,003	+789%	+$2.93M	0.15%	138
2024 Q2	$398K	Sell	2,789 -23,502	-89%	-$3.11M	0.02%	602
2024 Q1	$3.38M	Buy	26,291 +1,592	+6%	+$190K	0.18%	99
2023 Q4	$2.56M	Buy	+24,699	New	+$2.44M	0.08%	179
2022 Q4	–	Sell	-7,184	Closed	-$358K	–	1049
2022 Q3	$358K	Buy	+7,184	New	+$385K	0.02%	590
2022 Q2	–	Sell	-3,648	Closed	-$203K	–	969
2022 Q1	$203K	Sell	3,648 -8,814	-71%	-$452K	0.01%	741
2021 Q4	$698K	Buy	12,462 +5,876	+89%	+$318K	0.04%	383
2021 Q3	$316K	Sell	6,586 -37,050	-85%	-$1.79M	0.01%	820
2021 Q2	$1.83M	Buy	+43,636	New	+$1.69M	0.09%	256
2020 Q4	–	Sell	-7,732	Closed	-$268K	–	721
2020 Q3	$268K	Buy	+7,732	New	+$258K	0.02%	438
2020 Q2	–	Sell	-9,882	Closed	-$297K	–	512
2020 Q1	$297K	Sell	9,882 -12,106	-55%	-$360K	0.02%	315
2019 Q4	$636K	Sell	21,988 -25,996	-54%	-$720K	0.05%	172
2019 Q3	$1.24M	Buy	+47,984	New	+$1.21M	0.09%	140
2019 Q1	–	Sell	-37,842	Closed	-$872K	–	380
2018 Q4	$872K	Buy	37,842 +4,752	+14%	+$106K	0.05%	157
2018 Q3	$780K	Buy	+33,090	New	+$808K	0.09%	145
2018 Q2	–	Sell	-33,352	Closed	-$821K	–	241
2018 Q1	$821K	Buy	33,352 +24,440	+274%	+$642K	0.06%	113
2017 Q4	$239K	Sell	8,912 -21,920	-71%	-$557K	0.02%	151
2017 Q3	$742K	Buy	30,832 +19,958	+184%	+$451K	0.08%	115
2017 Q2	$233K	Buy	+10,874	New	+$219K	0.02%	193
2017 Q1	–	Sell	-19,270	Closed	-$346K	–	439
2016 Q4	$346K	Buy	19,270 +19,164	+18,079%	+$347K	0.02%	249
2016 Q3	$2K	Sell	106 -6,742	-98%	-$167K	﹤0.01%	381
2016 Q2	$184K	Buy	+6,848	New	+$188K	0.02%	181
2016 Q1	–	Sell	-1,668	Closed	-$48K	–	264
2015 Q4	$48K	Sell	1,668 -7,832	-82%	-$217K	0.01%	181
2015 Q3	$258K	Buy	+9,500	New	+$269K	0.07%	96
2015 Q1	–	Sell	-71,578	Closed	-$1.51M	–	212
2014 Q4	$1.51M	Buy	+71,578	New	+$1.6M	0.17%	62

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Flow Traders U.S.'s NVO Position: Q1 2026 in Review

Flow Traders U.S. reduced its Novo Nordisk (NVO) stake by 12% in Q1 2026, selling an estimated $189K and leaving 28,210 shares worth $1.04M. The position accounts for 0.03% of the portfolio, ranked #441.

Flow Traders U.S. first reported a position in NVO in Q4 2014 and has held it in 30 quarters since. The position peaked at $3.38M in Q1 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Flow Traders U.S. held 28,210 shares of Novo Nordisk worth $1.04M as of Q1 2026.
Flow Traders U.S. sold 3,986 Novo Nordisk shares in Q1 2026, an estimated $189K.
Novo Nordisk made up 0.03% of Flow Traders U.S.'s portfolio in Q1 2026, its #441 holding.
Flow Traders U.S. first reported a position in Novo Nordisk in Q4 2014 and has held it in 30 quarters since.
Flow Traders U.S.'s Novo Nordisk position peaked at $3.38M in Q1 2024.
1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.